Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study by Camilla Kjellstadli, Camilla Kjellstadli, Rachel B. Forster, Tor Å. Myklebust, Tor Å. Myklebust, Tone Bjørge, Tone Bjørge, Kaare H. Bønaa, Kaare H. Bønaa, Svein I. Helle, Rune Kvåle, Rune Kvåle

Get full text

Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer by Sophie D. Fosså, Anne Holck Storås, Kirsti Aas, Tom Børge Johannesen, Ylva Maria Gjelsvik, Tor Å. Myklebust

Get full text

Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population by Sophie D. Fosså, Alv A. Dahl, Tom Børge Johannesen, Ylva M. Gjelsvik, Anne Holck Storås, Tor Å. Myklebust

Get full text

Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge by Sophie D. Fosså, Lars J. Bjerner, Torgrim Tandstad, Marianne Brydøy, Alv A. Dahl, Ragnhild V. Nome, Helene Negaard, Tor Å. Myklebust, Hege S. Haugnes

Get full text

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors by B. Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, Andrea Lenartova, Mats Remberger, Ingerid Weum Abrahamsen, Geir Erland Tjønnfjord, Anders Eivind Myhre, Yngvar Fløisand, Tobias Gedde‐Dahl

Get full text